What question did this study set out to answer?

To critically review historical and recent clinical trial evidence regarding the therapeutic role, risks, and mortality impacts of corticosteroids in septic shock.

February 9, 2019Hospital PharmacyOpen Access

Corticosteroids for Septic Shock: Another Chapter in the Saga

View Full Paper

Ask AI

Bookmark

To critically review historical and recent clinical trial evidence regarding the therapeutic role, risks, and mortality impacts of corticosteroids in septic shock.
Critical narrative review analyzing four landmark and contemporary large clinical trials evaluating corticosteroid therapy.
Evaluation of study design variations, patient illness severity, and adjunctive shock management protocols across historical and modern data.
Corticosteroid administration dampens hyperinflammatory responses and shortens shock duration, but fails to demonstrate consistent reductions in patient mortality across major trials.
Hydrocortisone therapy provides maximal clinical value when targeted to patients presenting with septic shock and organ failure refractory to vasopressor treatment.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Review highlights inconsistent mortality benefits of corticosteroids in septic shock, indicating therapy is best reserved for refractory organ failure.

Cite This Study

Yerke et al. (2019) studied this question.

synapsesocial.com/papers/6a703d17e36a167817e1fdf5 https://doi.org/10.1177/0018578719829416

View Full Paper

Ask AI

Bookmark

Implication

Review highlights inconsistent mortality benefits of corticosteroids in septic shock, indicating therapy is best reserved for refractory organ failure.

Corticosteroids for Septic Shock: Another Chapter in the Saga

Key Points

Discussion

Implication

Cite This Study

Corticosteroids for Septic Shock: Another Chapter in the Saga

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider